Skip to main content
Top
Published in: Abdominal Radiology 4/2019

01-04-2019 | Classics in Abdominal Radiology

The little rose sign

Authors: Eric Delabrousse, Franck Grillet, Paul Calame

Published in: Abdominal Radiology | Issue 4/2019

Login to get access

Excerpt

The little rose sign first described by Romano et al. [1] refers to the aspect of ischemic colitis at the early stage of the disease on unenhanced CT. This typical feature corresponds to hyperdensity of mucosa and submucosal edema [2] (Figs. 1, 2). Ischemic colitis is considered a form of nonocclusive ischemic disease typically seen in the elderly [3]. Many precipitating factors such as atherosclerosis, hypotension, vasculitis, heart disease, cardiac and aortic surgery, and also some medications have been incriminated by reducing blood flow to the colon [3, 4]. Ischemic colitis presents two distinct patterns of severity [4, 5]. The histopathologic manifestations of ischemic colitis are either mucosal ulcerations, submucosal edema and hemorrhage or transmural infarction [3]. Presenting symptoms include abdominal pain and rectal bleeding. Since CT nowadays is performed in most patients presenting with an acute abdomen, radiologists should be aware of the CT appearance of this disease including the typical little rose sign that can help to distinguish an ischemic cause from the other causes of acute colitis (infectious, inflammatory) responsible for quite similar parietal thickening of the colon [6]. Most ischemic colitis diagnosed and treated at the early stage of the disease responds well to simple conservative treatment, while ischemic colitis seen at the late stage warrants surgical treatment [4].
Literature
1.
go back to reference Romano S, Lassandro F, Scaglione M, et al. (2006) Ischemia and infarction of the small bowel and colon: spectrum of imaging findings. Abdom Imaging 31:277–292CrossRefPubMed Romano S, Lassandro F, Scaglione M, et al. (2006) Ischemia and infarction of the small bowel and colon: spectrum of imaging findings. Abdom Imaging 31:277–292CrossRefPubMed
2.
go back to reference Romano S, Romano L, Grassi R (2007) Multidetector row computed tomography findings from ischemia to infarction of the large bowel. Eur J Radiol 61:433–441CrossRefPubMed Romano S, Romano L, Grassi R (2007) Multidetector row computed tomography findings from ischemia to infarction of the large bowel. Eur J Radiol 61:433–441CrossRefPubMed
3.
go back to reference Balthazar EJ, Yen BC, Gordon RB (1999) Ischemic colitis: evaluation of 54 cases. Radiology 211:381–388CrossRefPubMed Balthazar EJ, Yen BC, Gordon RB (1999) Ischemic colitis: evaluation of 54 cases. Radiology 211:381–388CrossRefPubMed
5.
go back to reference Berritto D, Iacobellis F, Mazzei MA, et al. (2016) MDCT in ischaemic colitis: how to define the aetiology and acute, subacute and chronic phase of damage in the emergency setting. Br J Radiol 89:20150821CrossRefPubMedPubMedCentral Berritto D, Iacobellis F, Mazzei MA, et al. (2016) MDCT in ischaemic colitis: how to define the aetiology and acute, subacute and chronic phase of damage in the emergency setting. Br J Radiol 89:20150821CrossRefPubMedPubMedCentral
6.
go back to reference Taourel P, Aufort S, Merigeaud S, et al. (2008) Imaging of ischemic colitis. Radiol Clin N Am 46:909–924CrossRefPubMed Taourel P, Aufort S, Merigeaud S, et al. (2008) Imaging of ischemic colitis. Radiol Clin N Am 46:909–924CrossRefPubMed
Metadata
Title
The little rose sign
Authors
Eric Delabrousse
Franck Grillet
Paul Calame
Publication date
01-04-2019
Publisher
Springer US
Published in
Abdominal Radiology / Issue 4/2019
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-018-1799-2

Other articles of this Issue 4/2019

Abdominal Radiology 4/2019 Go to the issue

Special Section: Distinguished Papers from JSAR

A case of human pancreatic eurytremiasis

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.